Using a multi-omics approach to identify novel targets in multiple myeloma

<p>Multiple myeloma (MM) is an incurable cancer of plasma cells, with an average five-year survival rate of approximately 50%. Over the last two decades, application of MM therapeutics, namely proteasome inhibitors (PI) and immunomodulatory imide drugs (IMiD), have almost doubled median surviv...

Popoln opis

Bibliografske podrobnosti
Glavni avtor: James-Bott, A
Drugi avtorji: Cribbs, A
Format: Thesis
Jezik:English
Izdano: 2022
Teme: